Finance

Lists
Outlook: 58.3% bullish·8.3% bearish
Go to analysis
MDWD:NASDAQ
Mediwound Ltd
$12.90
-0.54%
(-0.070) 1D
$12.90
0.00% (0.00)
After hours
Closed: Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MDWD...
Open
$13.00
High
$13.23
Low
$12.77
Mkt. cap
183.31M
Avg. vol.
132.85K
Volume
190.28K
52-wk high
$19.70
52-wk low
$11.80
EPS
-$1.60
Beta
0.07
Shares outstanding
12.91M
No. of employees
121
Open
$13.00
High
$13.23
Low
$12.77
Mkt. cap
183.31M
Avg. vol.
132.85K
Volume
190.28K
52-wk high
$19.70
52-wk low
$11.80
EPS
-$1.60
Beta
0.07
Shares outstanding
12.91M
No. of employees
121
News stories
From web sources and news partners
About Mediwound Ltd
CEOOfer Gonen
Employees121
Founded2000
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitemediwound.com
Analyst ratings
Based on 6 analysts giving stock ratings to MDWD in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for MDWD in the last 3 months.
Highest
Current $12.90
$36.00 (+179.07%)
Average
$29.67 (+130.00%)
Lowest
$25.00 (+93.80%)
Analyst
Recommendation
Action
Price target
Projected
Date
Chase Knickerbocker
Craig-Hallum
Buy
Maintained
$30.00
+132.6%
11/13/2026
Swayampakula Ramakanth
H.C. Wainwright
Buy
Maintained
$36.00
+179.1%
11/13/2026
Jeff Jones
Oppenheimer
Buy
Maintained
$30.00
+132.6%
11/13/2026
Josh Jennings
TD Cowen
Buy
Reiterated
$25.00
+93.8%
09/24/2026
Scott Henry
Alliance Global Partners
Buy
Reiterated
$27.00
+109.3%
09/16/2026
Michael Okunewitch
Maxim Group
Buy
Reiterated
$30.00
+132.6%
08/14/2026
Unknown Analyst
Oppenheimer
Buy
Maintained
$34.00
+163.6%
03/06/2026
Unknown Analyst
Alliance Global Partners
Buy
Maintained
$25.00
+93.8%
03/05/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.87M
1.48M
3.09M
3.57M
Cost of goods sold
1.59M
1.15M
2.76M
-
Cost of revenue
1.59M
1.15M
2.76M
-
Research and development expenses
4.48M
5.18M
5.90M
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.62M
3.56M
3.89M
-
Operating expense
8.08M
8.30M
9.80M
-
Total operating expenses
9.67M
9.46M
12.55M
-
Operating income
-7.80M
-7.98M
-9.46M
-
Other non operating income
1.74M
-
-
-
EBT including unusual items
-7.11M
-2.97M
-7.36M
-
EBT excluding unusual items
-7.11M
-2.97M
-7.36M
-
Income tax expense
73.00K
-17.00K
33.00K
-
Effective tax rate
-1.03%
0.57%
-0.45%
-
Other operating expenses
-17.00K
-439.00K
-
-
Net income
-7.18M
-2.95M
-7.39M
-
Net profit margin
-384.73%
-200.14%
-239.07%
-167.56%
Earnings per share
-0.56
-0.23
-0.57
-0.46
Interest and investment income
993.00K
5.01M
3.22M
-
Interest expense
-625.00K
-
-1.12M
-
Net interest expenses
368.00K
5.01M
2.10M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.55M
-7.60M
-9.06M
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps